Product NDC: | 62756-329 |
Proprietary Name: | EPINASTINE HYDROCHLORIDE |
Non Proprietary Name: | EPINASTINE HYDROCHLORIDE |
Active Ingredient(s): | .5 mg/mL & nbsp; EPINASTINE HYDROCHLORIDE |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62756-329 |
Labeler Name: | Sun Pharmaceutical Industries Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091626 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111101 |
Package NDC: | 62756-329-90 |
Package Description: | 1 BOTTLE in 1 CARTON (62756-329-90) > 5 mL in 1 BOTTLE |
NDC Code | 62756-329-90 |
Proprietary Name | EPINASTINE HYDROCHLORIDE |
Package Description | 1 BOTTLE in 1 CARTON (62756-329-90) > 5 mL in 1 BOTTLE |
Product NDC | 62756-329 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EPINASTINE HYDROCHLORIDE |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20111101 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharmaceutical Industries Limited |
Substance Name | EPINASTINE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |